Connection

Franco Locatelli to Hodgkin Disease

Back to Details
This is a "connection" page, showing publications Franco Locatelli has written about Hodgkin Disease.
Franco Locatelli
Connection Strength
0.869
Hodgkin Disease
  1. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematol. 2018 Oct; 5(10):e450-e461.
    View in: PubMed
    Score: 0.601
  2. Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy. Leuk Lymphoma. 2018 11; 59(11):2612-2621.
    View in: PubMed
    Score: 0.144
  3. The prognostic value of biological markers in paediatric Hodgkin lymphoma. Eur J Cancer. 2016 Jan; 52:33-40.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.